Theranostics 2022; 12(14):6157-6158. doi:10.7150/thno.77019 This issue

Erratum

FOSL2 promotes VEGF-independent angiogenesis by transcriptionnally activating Wnt5a in breast cancer-associated fibroblasts: Erratum

Xueying Wan1*, Shengdong Guan1*, Yixuan Hou2, Yilu Qin1, Huan Zeng1, Liping Yang1, Yina Qiao1, Shuiqing Liu1, Qiao Li1, Ting Jin1, Yuxiang Qiu1, Manran Liu1✉

1. Key Laboratory of Laboratory Medical Diagnostics, Chinese Ministry of Education, Chongqing Medical University, Chongqing 400016, China.
2. Experimental Teaching Center of Basic Medicine Science, Chongqing Medical University, Chongqing 400016, China.
*These authors contributed equally to this work.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Citation:
Wan X, Guan S, Hou Y, Qin Y, Zeng H, Yang L, Qiao Y, Liu S, Li Q, Jin T, Qiu Y, Liu M. FOSL2 promotes VEGF-independent angiogenesis by transcriptionnally activating Wnt5a in breast cancer-associated fibroblasts: Erratum. Theranostics 2022; 12(14):6157-6158. doi:10.7150/thno.77019. Available from https://www.thno.org/v12p6157.htm

File import instruction

Corrected-article in Theranostics, Volume 11, 4975